The Fellow on Call: The Heme/Onc Podcast cover image

Episode 101: Colorectal Cancer Series, Pt. 3 - Adjuvant Therapy in Stage II Colon Cancer and ctDNA

The Fellow on Call: The Heme/Onc Podcast

00:00

Exploring Immunotherapy for Stage II and III Colon Cancer

This chapter explores the potential of immunotherapy as a treatment for MMR deficient and MSI high tumors in stage II and III colon cancer. It discusses recent findings from the NICHE2 trial and underscores the significance of shared decision-making in enhancing patient outcomes.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app